Scilex Holding (SCLX) Total Debt (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Total Debt of $80.8 million for Q1 2026, up 104.81% year-over-year from $39.4 million in Q1 2025, and down 23.6% quarter-over-quarter from $105.7 million in Q4 2025.
Scilex Holding (SCLX) Total Debt (2021 - 2026) Analysis & Trends
Scilex Holding's Total Debt history runs 6 years deep, the most recent figure standing at $80.8 million for Q1 2026.
- In Q1 2026, Total Debt rose 104.81% year-over-year to $80.8 million; the TTM figure through Mar 2026 stood at $80.8 million (up 104.81% YoY), while the FY2025 annual figure was $105.7 million, up 196.02% from the prior year.
- Total Debt for Q1 2026 stood at $80.8 million, down from $105.7 million in the prior quarter.
- The five-year high for Total Debt was $125.5 million in Q4 2023, with the low at $2.0 million in Q2 2022.
- The 5-year median for Total Debt is $63.2 million (2025), against an average of $66.3 million.
- The sharpest annual moves came in 2023 and 2024: Total Debt soared 4010.62% in 2023, then sank 71.53% in 2024.
- Scilex Holding's Total Debt stood at $3.0 million in 2022, then surged by 4122.11% to $125.5 million in 2023, then plunged by 71.53% to $35.7 million in 2024, then jumped by 196.02% to $105.7 million in 2025, then retreated by 23.6% to $80.8 million in 2026.
- Business Quant data shows SCLX's Total Debt at $80.8 million in Q1 2026, $105.7 million in Q4 2025, and $45.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.15 Bn | 631.39 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.22 Bn | 463.65 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 375.23 Bn | 368.09 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 302.74 Bn | 295.05 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Astrazeneca | 257.45 Bn | 252.55 Bn | 12.86 Bn | 29.49 Bn |
| 6 | Amgen | 236.97 Bn | 222.98 Bn | 7.24 Bn | 62.75 Bn |
| 7 | Gilead Sciences | 182.72 Bn | 179.54 Bn | 6.22 Bn | 28.66 Bn |
| 8 | Pfizer | 159.94 Bn | 148.24 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Gsk | 106.14 Bn | 101.97 Bn | 8.24 Bn | -25.96 Bn |
| 10 | Scilex Holding | 39.94 Mn | -72.85 Mn | 3.97 Mn | 80.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.78 Mn |
| Dec 31, 2025 | 105.74 Mn |
| Sep 30, 2025 | 45.67 Mn |
| Jun 30, 2025 | 39.87 Mn |
| Mar 31, 2025 | 39.44 Mn |
| Dec 31, 2024 | 35.72 Mn |
| Sep 30, 2024 | 98.97 Mn |
| Jun 30, 2024 | 104.40 Mn |
| Mar 31, 2024 | 109.25 Mn |
| Dec 31, 2023 | 125.47 Mn |
| Sep 30, 2023 | 122.15 Mn |
| Jun 30, 2023 | 15.92 Mn |
| Sep 30, 2022 | 2.97 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Dec 31, 2021 | 109.99 Mn |